Overview: ESSA Pharma Inc. is a clinical-stage pharmaceutical company dedicated to developing small molecule drugs for prostate cancer treatment, with a market cap of $79.86 million. Operations: ESSA ...
"I've been working international fugitives with the FBI about 26 years… we've arrested a lot of bad guys," says FBI Special Agent Phil Torsney. "This is a once-in-a-lifetime case…and it was certainly ...
SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada, Oct. 9, 2025 /CNW/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") today announced the completion of XenoTherapeutics' ("Xeno") ...
While education professionals around the nation prepare for the implementation of the Every Student Succeeds Act, four educators—including a teacher, principal, district leader, and state chief—and a ...
HOUSTON, TX and VANCOUVER, Canada, Jan. 7, 2016/PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX: EPI; NASDAQ: EPIX) announced today that Dr. David Parkinson has been appointed as the ...
When President Barack Obama signed the Every Student Succeeds Act on Dec. 10, 2015, he called it a “Christmas miracle.” The law, which replaced the much-criticized No Child Left Behind Act, ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...
Essa Pharma is set to buy floundering Realm Therapeutics. The deal effectively sees Essa trade its shares for Realm’s cash, giving it the financial means to advance its pipeline of cancer drugs. Realm ...
ESSA Pharma (NASDAQ:EPIX) plummeted about 70% premarket on Friday after ending its Phase 2 trial for a prostate cancer treatment. The trial tested masofaniten with enzalutamide versus enzalutamide ...
The most recent version of the Elementary and Secondary Education Act, called the Every Student Succeeds Act (ESSA), included in its design an attempt to scale back some of the burdensome federal ...
The U.S. Department of Justice (DOJ) this week announced that it had secured a settlement of more than $3 million from Philadelphia, Penn.-based ESSA Bank & Trust over allegations that the company ...